OBJECTIVE: To identify neuromuscular, balance, and vision factors that contribute to falls in recently treated breast cancer survivors (BCS) and explore links between fall risk factors and cancer treatment. DESIGN: Case-control plus prospective observation. SETTING: Comprehensive cancer center. PARTICIPANTS: BCS (N=59; mean age, 58y) within 2 years of chemotherapy completion and/or on adjuvant endocrine therapy. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Objective measures of postural control, vision, and neuromuscular function included: (1) a sensory organization test (SOT), (2) a visual assessment battery, (3) muscle mass by dual energy x-ray absorptiometry, and (4) neuromuscular function with strength by repetition maximum, power by timed stair climb, and gait speed by 4m walk. Falls were self-reported for the past year (retrospective) and monthly for 6 months (prospective). RESULTS: Fifty eight percent of BCS reported falls in the past year. BCS with a history of falls had lower SOT scores with a vestibular deficit pattern in postural control (P<.01) and took longer to read letters on the contrast sensitivity chart (P<.05). Vestibular score on the SOT mediated the relationship between treatment and falls among BCS who received chemotherapy only, but not adjuvant endocrine therapy. CONCLUSIONS: Results of this project suggest that balance disturbances of vestibular origin and delays in detecting low contrast visual stimuli are associated with falls in BCS. Future studies that track falls and fall risk factors in BCS from diagnosis through treatment are warranted, as are studies that can identify treatment-related vestibular dysfunction and altered visual processing.
OBJECTIVE: To identify neuromuscular, balance, and vision factors that contribute to falls in recently treated breast cancer survivors (BCS) and explore links between fall risk factors and cancer treatment. DESIGN: Case-control plus prospective observation. SETTING: Comprehensive cancer center. PARTICIPANTS: BCS (N=59; mean age, 58y) within 2 years of chemotherapy completion and/or on adjuvant endocrine therapy. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Objective measures of postural control, vision, and neuromuscular function included: (1) a sensory organization test (SOT), (2) a visual assessment battery, (3) muscle mass by dual energy x-ray absorptiometry, and (4) neuromuscular function with strength by repetition maximum, power by timed stair climb, and gait speed by 4m walk. Falls were self-reported for the past year (retrospective) and monthly for 6 months (prospective). RESULTS: Fifty eight percent of BCS reported falls in the past year. BCS with a history of falls had lower SOT scores with a vestibular deficit pattern in postural control (P<.01) and took longer to read letters on the contrast sensitivity chart (P<.05). Vestibular score on the SOT mediated the relationship between treatment and falls among BCS who received chemotherapy only, but not adjuvant endocrine therapy. CONCLUSIONS: Results of this project suggest that balance disturbances of vestibular origin and delays in detecting low contrast visual stimuli are associated with falls in BCS. Future studies that track falls and fall risk factors in BCS from diagnosis through treatment are warranted, as are studies that can identify treatment-related vestibular dysfunction and altered visual processing.
Authors: Meredith A Wampler; Kimberly S Topp; Christine Miaskowski; Nancy N Byl; Hope S Rugo; Kate Hamel Journal: Arch Phys Med Rehabil Date: 2007-08 Impact factor: 3.966
Authors: Donald A Berry; Constance Cirrincione; I Craig Henderson; Marc L Citron; Daniel R Budman; Lori J Goldstein; Silvana Martino; Edith A Perez; Hyman B Muss; Larry Norton; Clifford Hudis; Eric P Winer Journal: JAMA Date: 2006-04-12 Impact factor: 56.272
Authors: Alvin Eisner; Maureen D Toomey; Julie Falardeau; John R Samples; John T Vetto Journal: Breast Cancer Res Treat Date: 2007-01-27 Impact factor: 4.872
Authors: Peter C Fino; Fay B Horak; Mahmoud El-Gohary; Carolyn Guidarelli; Mary E Medysky; Sarah J Nagle; Kerri M Winters-Stone Journal: Gait Posture Date: 2019-01-17 Impact factor: 2.840
Authors: Carmen L Wilson; Kimberley Dilley; Kirsten K Ness; Wendy L Leisenring; Charles A Sklar; Sue C Kaste; Marilyn Stovall; Daniel M Green; Gregory T Armstrong; Leslie L Robison; Nina S Kadan-Lottick Journal: Cancer Date: 2012-05-17 Impact factor: 6.860
Authors: Kerri M Winters-Stone; Jessica Dobek; Jill A Bennett; Lillian M Nail; Michael C Leo; Anna Schwartz Journal: J Cancer Surviv Date: 2011-12-23 Impact factor: 4.442
Authors: Scott M Monfort; Xueliang Pan; Robyn Patrick; Bhuvaneswari Ramaswamy; Robert Wesolowski; Michelle J Naughton; Charles L Loprinzi; Ajit M W Chaudhari; Maryam B Lustberg Journal: Breast Cancer Res Treat Date: 2017-04-03 Impact factor: 4.872
Authors: Mohsen Zahiri; Kevin M Chen; He Zhou; Hung Nguyen; Biruh T Workeneh; Sarvari V Yellapragada; Yvonne H Sada; Michael Schwenk; Bijan Najafi Journal: J Geriatr Oncol Date: 2019-01-18 Impact factor: 3.599
Authors: Coby Basal; Emily Vertosick; Theresa A Gillis; Qing Li; Ting Bao; Andrew Vickers; Jun J Mao Journal: Support Care Cancer Date: 2018-10-10 Impact factor: 3.603